Statins Impair CD1d-Mediated Antigen Presentation through the Inhibition of Prenylation

  • Khan M
  • Gallo R
  • Renukaradhya G
  • et al.
18Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

Statins are widely used as cholesterol-lowering agents that also decrease inflammation and target enzymes essential for prenylation, an important process in the activation and intracellular transport of proteins vital for a wide variety of cellular functions. Here, we report that statins impair a critical component of the innate immune response, CD1d-mediated Ag presentation. The addition of specific intermediates in the isoprenylation pathway reversed this effect, whereas specific targeting of enzymes responsible for prenylation mimicked the inhibitory effects of statins on Ag presentation by CD1d as well as MHC class II molecules. This study demonstrates the importance of isoprenylation in the regulation of Ag presentation and suggests a mechanism by which statins reduce inflammatory responses.

Cite

CITATION STYLE

APA

Khan, M. A., Gallo, R. M., Renukaradhya, G. J., Du, W., Gervay-Hague, J., & Brutkiewicz, R. R. (2009). Statins Impair CD1d-Mediated Antigen Presentation through the Inhibition of Prenylation. The Journal of Immunology, 182(8), 4744–4750. https://doi.org/10.4049/jimmunol.0804311

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free